18-343
Showing 1 - 25 of >10,000
Disease State of Oral Upadacitinib in Adolescent Participants
Recruiting
- Atopic Dermatitis
-
Ichinomiya-shi, Aichi, Japan
- +35 more
Jul 27, 2022
HER2-positive Gastric Cancer Trial in United States (Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel,
Recruiting
- HER2-positive Gastric Cancer
- Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel
- Cinrebafusp alfa (PRS-343) in combination with tucatinib
-
Santa Barbara, California
- +3 more
Jan 14, 2022
Tourette Syndrome Trial in Nashville (Ecopipam)
Recruiting
- Tourette Syndrome
-
Nashville, TennesseeAccess Clinical Trials, Inc.
Aug 28, 2023
HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Bladder Cancer Trial in United States (PRS-343 in
Unknown status
- HER2-positive Breast Cancer
- +3 more
- PRS-343 in Combination with Atezolizumab
-
Los Angeles, California
- +7 more
Jan 29, 2021
Colorectal Cancer, Cholangiocarcinoma Trial in United States (Medtronic pump and Codman catheter, Floxuridine (FUDR),
Active, not recruiting
- Colorectal Cancer
- Cholangiocarcinoma
- Medtronic pump and Codman catheter
- +6 more
-
Basking Ridge, New Jersey
- +6 more
Oct 3, 2022
Pulmonary Arterial Hypertension
Recruiting
- Pulmonary Disease
- Pulmonary Hypertension
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Rectal Cancer Trial in Detroit (Standard of care chemo with the change for avoidance of extensive surgery)
Recruiting
- Rectal Cancer
- Standard of care chemotherapy with the change for avoidance of extensive surgery
-
Detroit, MichiganAscension St. John Hospital
Jan 30, 2023
Stage IB-IIIA Non-small Cell Lung Carcinoma Trial in Worldwide (AZD9291 80 mg/40 mg, Placebo AZD9291 80 mg/40 mg, Open-label
Active, not recruiting
- Stage IB-IIIA Non-small Cell Lung Carcinoma
- AZD9291 80 mg/40 mg
- +2 more
-
Los Angeles, California
- +240 more
Jan 12, 2023
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)
Not yet recruiting
- Glioblastoma
- +2 more
- SonoCloud-9 (SC9)
- +3 more
-
Chicago, Illinois
- +7 more
Jun 5, 2023
Neurodevelopmental Disorders Trial in Montréal (NeuroN-QI, SSC alone)
Not yet recruiting
- Neurodevelopmental Disorders
- NeuroN-QI
- SSC alone
-
Montréal, Quebec, CanadaCHU Sainte-Justine
Oct 11, 2023
Frailty in Critical Care Unit's Patients
Not yet recruiting
- CFS
- Assesment of CFS
- (no location specified)
Nov 2, 2023
Upper Limb Motor Performance UsingInterface With Haptic Feedback
Not yet recruiting
- Healthy
- Functional test with a haptic device
-
Oro Verde, Entre Ríos, ArgentinaFacultad de Ingeniería, Universidad Nacional de Entre Ríos
Apr 19, 2023
Hypertension, Pulmonary Trial in Worldwide (Riociguat (Adempas, BAY63-2521))
Active, not recruiting
- Hypertension, Pulmonary
- Riociguat (Adempas, BAY63-2521)
-
Cali, Valle Del Cauca, Colombia
- +15 more
Jan 18, 2023
Plasma Cell Myeloma Trial in United States (Ixazomib Citrate, Lenalidomide, Placebo Administration)
Recruiting
- Plasma Cell Myeloma
- Ixazomib Citrate
- +4 more
-
Phoenix, Arizona
- +221 more
Jan 28, 2023
Children That Might be at Risk of Having Retinal Hemorrhages
Not yet recruiting
- Retinal Hemorrhage, Bilateral
- +2 more
- ophthalmoscopy and fundus photography through dilated pupills
- (no location specified)
Oct 18, 2022
HIV Trial in United States (Indinavir sulfate, Lamivudine, Stavudine)
Completed
- HIV Infections
- Indinavir sulfate
- +3 more
-
Los Angeles, California
- +44 more
Oct 28, 2021
Arthroplasty, Replacement, Knee Trial in New York (Melatonin 5 mg, Placebo (Vitamin C))
Recruiting
- Arthroplasty
- +3 more
- Melatonin 5 mg
- Placebo (Vitamin C)
-
New York, New YorkHospital for Special Surgery
Aug 25, 2022
Pelvic Pain Trial in Beaumont (MILTA Device, " control 1 " fake MILTA device)
Recruiting
- Pelvic Pain
- MILTA Device
- " control 1 " fake MILTA device
-
Beaumont, FranceClinique la Chataigneraie
Jul 20, 2022
Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Olaparib, Pembrolizumab)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Olaparib
- Pembrolizumab
-
Anchorage, Alaska
- +513 more
Jan 28, 2023
Healthy Trial in Abbottabad (Left Nostril Breathing, Conventional)
Not yet recruiting
- Healthy
- Left Nostril Breathing
- Conventional
-
Abbottābād, KPK, PakistanWomen Instritute of Rehabilitation Sciences, Jinnah College of N
May 26, 2023
After EPL-rupture After Distal Radius Fracture
Not yet recruiting
- Distal Radius Fracture
- primary suture
- EIP-transfer
- (no location specified)
Mar 2, 2022